Follow
Valerie Chew
Valerie Chew
Translational Immunology Institute (TII)
Verified email at duke-nus.edu.sg - Homepage
Title
Cited by
Cited by
Year
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
V Chew, J Chen, D Lee, E Loh, J Lee, KH Lim, A Weber, K Slankamenac, ...
Gut 61 (3), 427-438, 2012
3162012
Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
M Garnelo, A Tan, Z Her, J Yeong, CJ Lim, J Chen, KH Lim, A Weber, ...
Gut 66 (2), 342-351, 2017
2852017
Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
V Chew, C Tow, M Teo, HL Wong, J Chan, A Gehring, M Loh, A Bolze, ...
Journal of hepatology 52 (3), 370-379, 2010
2692010
Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma
CJ Lim, YH Lee, L Pan, L Lai, C Chua, M Wasser, TKH Lim, J Yeong, ...
Gut 68 (5), 916-927, 2019
1422019
Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses
V Chew, L Lai, L Pan, CJ Lim, J Li, R Ong, C Chua, JY Leong, KH Lim, ...
Proceedings of the National Academy of Sciences 114 (29), E5900-E5909, 2017
1422017
Immune microenvironment in tumor progression: characteristics and challenges for therapy
V Chew, HC Toh, JP Abastado
Journal of oncology 2012, 2012
1402012
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
V Chew, YH Lee, L Pan, NJM Nasir, CJ Lim, C Chua, L Lai, SN Hazirah, ...
Gut 68 (2), 335-346, 2019
1292019
PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity
TS Lim, V Chew, JL Sieow, S Goh, JPS Yeong, AL Soon, ...
Oncoimmunology 5 (3), e1085146, 2016
1242016
Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model
EA Bard-Chapeau, AT Nguyen, AG Rust, A Sayadi, P Lee, BQ Chua, ...
Nature genetics 46 (1), 24-32, 2014
1072014
Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients
V Chew, C Tow, C Huang, E Bard-Chapeau, NG Copeland, NA Jenkins, ...
JNCI: Journal of the National Cancer Institute 104 (23), 1796-1807, 2012
912012
TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
V Ho, TS Lim, J Lee, J Steinberg, R Szmyd, M Tham, J Yaligar, P Kaldis, ...
Oncotarget 6 (29), 27252, 2015
632015
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
PHD Nguyen, S Ma, CZJ Phua, NA Kaya, HLH Lai, CJ Lim, JQ Lim, ...
Nature communications 12 (1), 1-13, 2021
582021
An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use
JCT Lim, JPS Yeong, CJ Lim, CCH Ong, SC Wong, VSP Chew, ...
Pathology 50 (3), 333-341, 2018
502018
Combinational immunotherapy for hepatocellular carcinoma: radiotherapy, immune checkpoint blockade and beyond
YH Lee, D Tai, C Yip, SP Choo, V Chew
Frontiers in Immunology 11, 568759, 2020
382020
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
HHM Ng, RY Lee, S Goh, ISY Tay, X Lim, B Lee, V Chew, H Li, B Tan, ...
Journal for immunotherapy of cancer 8 (2), 2020
372020
Expression of CD38 on macrophages predicts improved prognosis in hepatocellular carcinoma
JH Lam, HHM Ng, CJ Lim, XN Sim, F Malavasi, H Li, JJH Loh, K Sabai, ...
Frontiers in immunology, 2093, 2019
362019
Leupaxin negatively regulates B cell receptor signaling
V Chew, KP Lam
Journal of Biological Chemistry 282 (37), 27181-27191, 2007
332007
High-dimensional immune-profiling in cancer: implications for immunotherapy
S Chuah, V Chew
Journal for immunotherapy of cancer 8 (1), 2020
322020
Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands
V Chew, JP Abastado
Oncoimmunology 2 (4), e23493, 2013
282013
Rationale of immunotherapy in hepatocellular carcinoma and its potential biomarkers
D Tai, SP Choo, V Chew
Cancers 11 (12), 1926, 2019
252019
The system can't perform the operation now. Try again later.
Articles 1–20